Dhanuka Agritech Sees Q1 Decline, Approves ₹200 Crore Nagpur Plant

Dhanuka Agritech's revenue from operations for the quarter ended June 30, 2026, declined by 13% to ₹461.93 crore, down from ₹528.29 crore in the same period last year. Profit for the period also saw a significant drop of 35%, falling to ₹36.30 crore from ₹55.50 crore year-over-year. Basic Earnings Per Share (EPS) decreased to ₹8.06 from ₹12.31.

Reader Takeaway: Seasonal revenue dip contrasts with strategic expansion and buyback.

What just happened

Dhanuka Agritech reported a year-over-year decline in revenue and profit for the first quarter of fiscal year 2027 (ended June 30, 2026). Revenue fell 13% to ₹461.93 crore, and profit decreased 35% to ₹36.30 crore. The company attributed these variations to the seasonal nature of the agrochemical business, which is influenced by monsoons, pest infestation, and crop patterns.

Why this matters

The results reflect the inherent cyclicality of the agrochemical sector. While the quarterly performance may be a concern, the company's proactive investment in future growth through a new manufacturing unit and its completed share buyback program signal strategic capital allocation. Investors will be watching the balance between seasonal volatility and long-term capacity building.

The backstory

Dhanuka Agritech is a prominent player in the Indian agrochemical industry, offering a wide range of crop protection and specialty plant nutrient products. The company's performance is traditionally tied to agricultural cycles and weather patterns in India.

What changes now

The Board of Directors has approved an investment of up to ₹200 crore to establish a new pesticide manufacturing unit with a capacity of 23,000 MT per annum in Nagpur, Maharashtra. This unit is expected to be operational by March/April 2028 and aims to improve logistical efficiency by positioning the company closer to its key markets in South, East, and Central India. Additionally, Dhanuka Agritech completed a share buyback of 5,00,000 equity shares at ₹1,400 per share, totalling ₹70 crore, which were extinguished on June 20, 2026. The Board also approved a loan of up to ₹15 crore for the 'Dhanuka Stock Appreciation Rights Plan, 2026'.

Risks to watch

The primary risk remains the dependence on monsoon patterns and pest infestations, which can significantly impact sales and profitability. Execution risk for the new Nagpur plant, including timely completion and cost overruns, will also be a key factor. Managing the proposed employee stock plan effectively is also important for shareholder value.

Peer comparison

(No direct peer comparison data available in the filing)

Context metrics (time-bound)

• Revenue (Q1 FY27): ₹461.93 crore (down 13% YoY)
• Profit (Q1 FY27): ₹36.30 crore (down 35% YoY)
• Share Buyback: ₹70 crore completed.
• New Plant Investment: Up to ₹200 crore approved for Nagpur facility.
• Plant Operational Date: Expected by March/April 2028.

What to track next

Investors should monitor the progress of the Nagpur manufacturing unit, future quarterly results in relation to seasonal expectations, and the impact of any new product launches or market expansions.